Skip to main content

Table 1 Baseline demographics and OCT characteristics in each group

From: Features of optical coherence tomography angiography in age-related macular degeneration with residual fluid after three loading doses of aflibercept

Parameter

Group 1 (n = 65)

Group 2 (n = 36)

P value

Age (years)

69.5 ± 7.5

70.3 ± 7.6

0.626*

Sex (male, %)

21 (32.3)

9 (25.0)

0.441

Spherical equivalent (diopter)

0.15 ± 1.48

0.53 ± 1.14

0.183*

Intraocular pressure (mmHg)

13.8 ± 3.3

13.9 ± 3.5

0.788*

Axial length (mm)

23.6 ± 0.8

24.0 ± 0.9

0.066*

Baseline BCVA (logMAR)

0.53 ± 0.60

0.44 ± 0.34

0.441*

MNV type (1:2)

42:23

18:18

0.152

CT (µm)

264.4 ± 81.3

258.9 ± 79.6

0.746*

CMT (µm)

390.7 ± 110.0

394.0 ± 105.7

0.885*

PED height (µm)

194.5 ± 157.0

168.3 ± 129.4

0.397*

Fluid type

  

0.478

 SRF (n, %)

39 (60.0)

26 (72.2)

 

 IRF (n, %)

4 (6.2)

1 (2.8)

 

 Both (n, %)

22 (33.8)

9 (25.0)

 

 Hyperreflective foci (n, %)

55 (84.6)

34 (94.4)

0.432

 SHRM (n, %)

23 (35.4)

17 (47.2)

0.269

Prechoroidal cleft (n, %)

1 (0.5)

2 (5.6)

0.261

  1. OCT = optical coherence tomography; BCVA = best-corrected visual acuity; MNV = macular neovascularization; CT = choroidal thickness; CMT = central macular thickness; PED = pigment epithelium detachment; SRF = subretinal fluid; IRF = intraretinal fluid; SHRM = subretinal hyperreflective material
  2. Data are presented as mean ± standard deviation unless otherwise stated
  3. *Independent t-test; Chi-squared test